INO 6172
Alternative Names: INO-6172Latest Information Update: 08 Apr 2024
At a glance
- Originator Inovio Pharmaceuticals
- Developer Inovio Pharmaceuticals; National Institute of Allergy and Infectious Diseases
- Class AIDS vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I HIV infections